Bluebird’s CALD therapy gets FDA accelerated approval
A revolutionary cell-based treatment for cerebral adrenoleukodystrophy, otherwise known as CALD, received accelerated approval from the Food and Drug Administration (FDA) on Friday. Developed […]
Bluebird’s CALD therapy gets FDA accelerated approval Read More »